BeOne Medicines AG
ONC
$335.17
$2.460.74%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 124.84M | 94.32M | 1.27M | -139.70M | -121.35M |
| Total Depreciation and Amortization | 35.75M | 29.87M | 31.63M | 167.03M | 70.11M |
| Total Amortization of Deferred Charges | 1.54M | 5.75M | 1.17M | 4.73M | 1.19M |
| Total Other Non-Cash Items | 140.41M | 128.31M | 88.04M | 236.71M | 107.96M |
| Change in Net Operating Assets | 100.02M | 5.35M | -78.03M | -157.17M | 130.47M |
| Cash from Operations | 402.55M | 263.60M | 44.08M | 111.61M | 188.37M |
| Capital Expenditure | -48.08M | -43.83M | -56.41M | -87.76M | -133.66M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.19M | -22.78M | -65.53M | -159.55M | -227.00K |
| Cash from Investing | -49.27M | -66.61M | -121.94M | -247.32M | -133.88M |
| Total Debt Issued | 0.00 | 141.52M | 80.00M | 548.58M | 0.00 |
| Total Debt Repaid | -4.26M | -115.45M | -177.14M | -558.78M | -3.56M |
| Issuance of Common Stock | 80.54M | 33.14M | 63.36M | 3.85M | 16.22M |
| Repurchase of Common Stock | 0.00 | -24.20M | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -14.49M |
| Other Financing Activities | 885.00M | -- | -- | 22.20M | 0.00 |
| Cash from Financing | 961.27M | 35.03M | -33.78M | 30.05M | 12.66M |
| Foreign Exchange rate Adjustments | 9.91M | 23.48M | 3.48M | -49.99M | 28.35M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.32B | 255.50M | -108.16M | -155.64M | 95.50M |